Abstract | OBJECTIVE: STUDY DESIGN: Patients were randomly assigned to the experimental group (1.4 mg intralesional betamethasone) or to the control group (8 mg intralesional triamcinolone acetonide), and they received injections once a week for 2 weeks. Erosive area and pain level were assessed on days 1, 7 ± 2, and 14 ± 2. If the lesion disappeared, any recurrence within the following 3 months was recorded. RESULTS: Twenty-nine participants in the experimental group and 30 in the control group completed the protocol. Healed percentage was higher with betamethasone (93.1%) than with triamcinolone (66.7%; P = .02), and final reduction in erosion area was greater in the experimental group (21.276 ± 21.064 mm(2)) than in the control group (11.5 ± 12.95 mm(2); P = .02). Reduction in pain level did not differ between groups. The proportion of participants with recurrent erosions was significantly lower in the experimental group (14.8%) than in the control group (45%; P = .04). CONCLUSIONS:
|
Authors | Chuanxia Liu, Bing Xie, Yi Yang, Duanxian Lin, Caixia Wang, Mei Lin, Lin Ge, Hongmei Zhou |
Journal | Oral surgery, oral medicine, oral pathology and oral radiology
(Oral Surg Oral Med Oral Pathol Oral Radiol)
Vol. 116
Issue 5
Pg. 584-90
(Nov 2013)
ISSN: 2212-4411 [Electronic] United States |
PMID | 24119523
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- Glucocorticoids
- Betamethasone
- Triamcinolone Acetonide
|
Topics |
- Adolescent
- Adult
- Betamethasone
(administration & dosage, therapeutic use)
- Female
- Glucocorticoids
(administration & dosage, therapeutic use)
- Humans
- Injections, Intralesional
- Lichen Planus, Oral
(drug therapy)
- Male
- Middle Aged
- Pain Measurement
- Recurrence
- Treatment Outcome
- Triamcinolone Acetonide
(administration & dosage, therapeutic use)
|